scientific reports
Check for updates
OPEN Publisher Correction: Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy
Published online: 11 November 2025
Zahra Jafari, Seyed-Morteza Javadirad & Seyede Elmira Yazdi Rouholamini Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-10452-w, published online 17 July 2025 The original version of this Article contained an error in Fig. 8, where the Y axes did not display correctly. The published incorrect Fig. 8 and its legend appear below.
The original Article has been corrected.
a. TOP2A
b. CDK1
c. CCNB1
100
100
100
80
80
80
0 ::
60
0 ::
60
8
60
40
40
40
20
AUC=0.98
20
AUC=0.98±0.01
20
±0.01
Pvalue<0.0001
AUC=0.97±0.01
0
Pvalue<0.0001
0
Pvalue<0.0001
0
20
40
60
80
100
0
20
40
60
80
100
0
0
20
40
60
80
100
FPR
FPR
FPR
d. PCLAF
e. ZWINT
f. UBE2T
100
100
100
80
80
80
0 :::
60
0 ::
A
60
60
P.
40
40
40
20
AUC=0.96±0.02
20
Pvalue<0.0001
AUC=0.95±0.02
20
AUC=0.95±0.01
Pvalue<0.0001
Pvalue<0.0001
0
0
0
0
20
40
60
80
100
0
20
40
60
80
100
0
20
40
60
80
100
FPR
FPR
FPR
AUC=0.9632
g. PRC1
h. HMMR
i.
TYMS
1.0
100
100
80
80
0 ::
0 :::
P.
60
0 ::
60
a. 0.5 I-
2.
40
40
AUC=0.94±0.02 Pvalue<0.0001
20
AUC=0.94±0.02 Pvalue<0.0001
20
AUC=0.94±0.02 Pvalue<0.0001
0.0
0
0
0.0
0.5
1.0
0
20
40
60
80
100
0
20
40
60
80
100
FPR
FPR
FPR
j. RACGAP1
k. UBE2C
100
100
80
80
0 ::
a:
60
0 ::
60
40
40
20
AUC=0.93±0.03
20
AUC=0.93±0.03
0
Pvalue<0.0001
Pvalue<0.0001
0
0
20
40
60
80
100
0
20
40
60
80
100
FPR
FPR
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommo ns.org/licenses/by-nc-nd/4.0/.
@ The Author(s) 2025